USANA Health Sciences (NYSE:USNA – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported $0.56 earnings per share for the quarter, topping analysts’ consensus estimates of $0.49 by $0.07, Yahoo Finance reports. The business had revenue of $200.22 million during the quarter, compared to the consensus estimate of $208.45 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.80%. During the same quarter in the prior year, the firm posted $0.59 earnings per share. USANA Health Sciences updated its FY 2024 guidance to 2.450-2.450 EPS.
USANA Health Sciences Stock Up 6.1 %
USNA opened at $36.58 on Thursday. USANA Health Sciences has a twelve month low of $34.15 and a twelve month high of $55.45. The company has a 50-day moving average price of $37.98 and a 200 day moving average price of $42.55. The company has a market cap of $696.85 million, a PE ratio of 12.93, a price-to-earnings-growth ratio of 1.15 and a beta of 0.89.
Wall Street Analyst Weigh In
A number of research analysts have weighed in on USNA shares. StockNews.com downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 24th. DA Davidson decreased their price objective on shares of USANA Health Sciences from $38.00 to $35.00 and set a “neutral” rating for the company in a research report on Wednesday.
Insider Buying and Selling
In related news, insider Paul A. Jones sold 6,266 shares of the company’s stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $38.38, for a total transaction of $240,489.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Gilbert A. Fuller sold 674 shares of the company’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $39.69, for a total transaction of $26,751.06. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Paul A. Jones sold 6,266 shares of the company’s stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $38.38, for a total transaction of $240,489.08. The disclosure for this sale can be found here. Insiders sold a total of 7,940 shares of company stock worth $311,670 in the last 90 days. Insiders own 0.33% of the company’s stock.
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Further Reading
- Five stocks we like better than USANA Health Sciences
- Top Stocks Investing in 5G Technology
- Goldman’s Lost Decade Forecast: These 3 Growth Stocks Can Win
- Most active stocks: Dollar volume vs share volume
- WD-40 Company Gears Up for a Double-Digit Stock Advance
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Monster and Celsius Energized: Which Stock Offers More Upside?
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
